- ￥4520
- Sino Biological
- 北京
- 11684-V27H-B
- 2026年01月26日
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
阿拉丁试剂，充足现货，稳定批间差Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-20℃ to -80℃
- 保质期：
12个月
- 英文名：
Recombinant H1N1 HA-specific B cell probe(Y108F,AVI & His Tag),Biotinylated
- 库存：
99
- 供应商：
北京义翘神州科技股份有限公司
- 规格：
20.00 µg
蛋白名称：Influenza A H1N1 (strain A/Puerto Rico/8/1934) Hemagglutinin / HA-specific B cell probe Protein (Y108F, AVI & His Tag), Biotinylated
蛋白构建：A DNA sequence encoding the Influenza A virus (strain A/Puerto Rico/8/1934 (H1N1)) hemagglutinin (P03452) (Met1-Gly518, with a mutation Tyr108Phe), termed as HA, was expressed with a c-terminal AVI tagged polyhistidine tag at the C-terminus. The expressed protein was biotinylated in vivo by the Biotin-Protein ligase (BirA enzyme) which is co-expressed.
表达宿主：HEK293 Cells
蛋白纯度：≥ 95 % as determined by SDS-PAGE. ≥ 95 % as determined by SEC-HPLC.
蛋白内毒素：< 1.0 EU per μg protein as determined by the LAL method.
预测N端：Asp 18
蛋白分子量：The recombinant Influenza A virus ((strain A/Puerto Rico/8/1934) (H1N1))Hemagglutinin / HA comprises 557 amino acids and has a predicted molecular mass of 63.13 kDa. It migrates as an approximately 64.2 kDa band in SDS-PAGE under reducing conditions.
蛋白NP号：P03452
蛋白氨基酸序列：Met1-Gly518
蛋白标签：C-AVI & His
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验科研人必看：多肽、蛋白质、重组蛋白分不清？ 应用场景有哪些？定制如何选？
Section.01 多肽 VS 蛋白质 VS 重组蛋白 多肽、蛋白质和重组蛋白本质上都是由氨基酸组成的生物大分子，三者的主要区别在于分子大小、折叠结构以及生产方式： 弄清区别只是第一步。在实际应用中，抗体筛选、靶点验证、药物递送等场景，经常需要特定序列的多肽或非天然来源的重组蛋白。这时候，成品库里的选项远远不够。于是，您需要选择「多肽 & 重组蛋白定制服务」。 Section.02 多肽定制
Overview of Protein Microarrays
labeling or using a reporter antibody in sandwich assay format. (B ) Functional protein microarrays have broad applications in studying protein interactions, including protein binding and enzyme‐substrate reactions. (C ) Reverse‐phase protein microarrays
Genetic Engineering of Live Attenuated Influenza Viruses
The first live attenuated influenza vaccine (LAIV) was licensed in the USA in 2003; it is a trivalent vaccine composed of two type A (H1N1 and H3N2) and one type B influenza virus each at 107 fluorescent focus units (FFU). Each influenza
技术资料暂无技术资料 索取技术资料
